Calyx Completes Non-Brokered Private Placement
November 10th, 2017 – Vancouver, British Columbia – Calyx Bio-Ventures Inc. (TSXV: CYX) (“Calyx” or the “Company”) is pleased to announce that it has completed a non-brokered private placement of 14,857,143 units (each, a “Unit”), at a price of $0.07 per Unit, for gross proceeds of $1,040,000. Each Unit consists one common share of the Company, and one-half-of-one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant is exercisable to acquire one additional common share of the Company at a price of $0.15 per share for a period of twenty-four months.
All securities issued in connection with the private placement are subject to a four-month-and- one-day statutory hold period expiring on March 11th, 2018. In connection with closing of the private placement, the Company paid a cash commission of $2,100.
The Company is also pleased to announce that it has entered into a letter of intent to lease and build out an additional facility that will house the Company’s new corporate head office and a “state of the art” environment to execute on its strategic plan to deploy its first data mining facility and to provide additional space to better support operations and ongoing business development.
Calyx’s wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform originally designed for advanced indoor agriculture. The original Cannigistics software platform was designed to enhance the efficiency and effectiveness of indoor agricultural operations, but has significantly evolved to include a wide range of other industries. This now positions Cannigistics to be a leader (in not only agri-software industry), but a leader in many other industries. Additionally, the Company continues to own a portfolio of proprietary intellectual property with applications in crop enhancement and additionally messaging software assets.
For further information about Calyx, please visit www.calyxbio.com or contact:
President and Chief Executive Officer
Calyx Bio-Ventures Inc.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.